Correspondingly, fucoidan suppressed cancer cell migration and invasion in human lung cancer cells (A549 cells) via inhibition of MMP-2, wherein blocking of the ERK1/2 and PI3K-AKT-mTOR pathways was associated with the MMP-2-related anti-cancer effects of fucoidan [46]. Here, AKT1 is linked to lung cancer.